Search

Search Results
Results 6741 - 6750 of 7262 for Anti-aging"
  • Amitriptyline Viatris (formerly Amitriptyline Alphapharm)
    Drug - 21 Feb 2025
    Consumer Medicine Information (CMI) about Amitriptyline Viatris (formerly Amitriptyline Alphapharm) intended for persons living in Australia.
  • Peptide Therapy: The Future of Targeted Treatment?
    Health - 17 Feb 2025
    Peptide therapy enhances targeted medicine, utilizing specific peptides for effective treatment of cancer, metabolic disorders, and neurodegenerative diseases.
  • Alpha-GPC: What Science Says About Its Role in Brain Health
    Health - 14 Feb 2025
    Alpha-GPC, a choline-rich supplement, enhances brain health by increasing acetylcholine, with potential applications in neurodegenerative disease prevention.
  • Premarin
    Drug - 14 Feb 2025
    Consumer Medicine Information (CMI) about Premarin (Conjugated estrogens Tablets) intended for persons living in Australia.
  • Combivir
    Drug - 13 Feb 2025
    Consumer Medicine Information (CMI) about Combivir intended for persons living in Australia.
  • Kalydeco
    Drug - 7 Feb 2025
    Consumer Medicine Information (CMI) about Kalydeco intended for persons living in Australia.
  • Cabenuva
    Drug - 30 Jan 2025
    Consumer Medicine Information (CMI) about Cabenuva intended for persons living in Australia.
  • Retevmo
    Drug - 28 Jan 2025
    Consumer Medicine Information (CMI) about Retevmo intended for persons living in Australia.
  • Edurant
    Drug - 24 Jan 2025
    Consumer Medicine Information (CMI) about Edurant intended for persons living in Australia.
  • Aspalgin
    Drug - 21 Jan 2025
    Consumer Medicine Information (CMI) about Aspalgin intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback